Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRING - Seizure Prophylaxis in Glioma
2018-001312-30Phase 3Unknown
- Sponsor
- NHS National Services Scotland
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levetiracetam in glioma and seizure, sponsored by NHS National Services Scotland. Primary endpoint: One-year risk of first seizure. Status: unknown.
02
Drugs
levetiracetam
03
Conditions
gliomaseizure
Beyond the preview
Go deeper on 2018-001312-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001312-30.